Andersen CF, Larsen JH, Jensen J, Omar M, et al. Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program. Am Heart J 2024 Feb 14:S0002-8703(24)00032-2. doi: 10.1016/j.ahj.2024.
PMID: 38365073